Author | R. Kate Kelley | OncLive

Author | R. Kate Kelley

Articles

Dr. Kelley on Newly Approved Agents in HCC

March 15, 2018

Video

R. Kate Kelley, MD, associate professor of clinical medicine, Department of Medicine, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the clinical impact of REFLECT and CELESTIAL in hepatocellular carcinoma (HCC).

x